vs
Alarm.com Holdings, Inc.（ALRM）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Alarm.com Holdings, Inc.的季度营收约是Orthofix Medical Inc.的1.2倍（$261.7M vs $219.9M），Alarm.com Holdings, Inc.净利率更高（13.2% vs -1.0%，领先14.2%），Alarm.com Holdings, Inc.同比增速更快（8.0% vs 2.0%），Alarm.com Holdings, Inc.自由现金流更多（$35.1M vs $16.8M），过去两年Alarm.com Holdings, Inc.的营收复合增速更高（8.3% vs 8.0%）
Alarm.com Holdings, Inc.是一家美国科技企业，成立于2000年，由微策略公司分拆而来，总部位于弗吉尼亚州泰森斯。公司主营云服务，为用户提供远程控制、智能家居及报警监测相关解决方案，是家庭智能安防领域的重要服务商。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
ALRM vs OFIX — 直观对比
营收规模更大
ALRM
是对方的1.2倍
$219.9M
营收增速更快
ALRM
高出6.0%
2.0%
净利率更高
ALRM
高出14.2%
-1.0%
自由现金流更多
ALRM
多$18.2M
$16.8M
两年增速更快
ALRM
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $261.7M | $219.9M |
| 净利润 | $34.6M | $-2.2M |
| 毛利率 | 66.0% | 71.1% |
| 营业利润率 | 13.4% | 0.2% |
| 净利率 | 13.2% | -1.0% |
| 营收同比 | 8.0% | 2.0% |
| 净利润同比 | 14.8% | 92.4% |
| 每股收益（稀释后） | $0.66 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALRMOFIX
| Q4 25 | $261.7M | $219.9M | ||
| Q3 25 | $256.4M | $205.6M | ||
| Q2 25 | $254.3M | $203.1M | ||
| Q1 25 | $238.8M | $193.6M | ||
| Q4 24 | $242.2M | $215.7M | ||
| Q3 24 | $240.5M | $196.6M | ||
| Q2 24 | $233.8M | $198.6M | ||
| Q1 24 | $223.3M | $188.6M |
净利润ALRMOFIX
| Q4 25 | $34.6M | $-2.2M | ||
| Q3 25 | $35.1M | $-22.8M | ||
| Q2 25 | $34.2M | $-14.1M | ||
| Q1 25 | $27.7M | $-53.1M | ||
| Q4 24 | $30.1M | $-29.1M | ||
| Q3 24 | $36.7M | $-27.4M | ||
| Q2 24 | $33.5M | $-33.4M | ||
| Q1 24 | $23.6M | $-36.0M |
毛利率ALRMOFIX
| Q4 25 | 66.0% | 71.1% | ||
| Q3 25 | 65.8% | 72.2% | ||
| Q2 25 | 65.6% | 68.7% | ||
| Q1 25 | 67.2% | 62.8% | ||
| Q4 24 | 65.5% | 69.0% | ||
| Q3 24 | 64.8% | 68.7% | ||
| Q2 24 | 65.2% | 67.8% | ||
| Q1 24 | 65.7% | 67.5% |
营业利润率ALRMOFIX
| Q4 25 | 13.4% | 0.2% | ||
| Q3 25 | 14.4% | -8.3% | ||
| Q2 25 | 12.6% | -7.9% | ||
| Q1 25 | 12.4% | -25.2% | ||
| Q4 24 | 12.7% | -5.3% | ||
| Q3 24 | 13.8% | -9.6% | ||
| Q2 24 | 11.0% | -12.5% | ||
| Q1 24 | 8.4% | -15.6% |
净利率ALRMOFIX
| Q4 25 | 13.2% | -1.0% | ||
| Q3 25 | 13.7% | -11.1% | ||
| Q2 25 | 13.5% | -6.9% | ||
| Q1 25 | 11.6% | -27.4% | ||
| Q4 24 | 12.4% | -13.5% | ||
| Q3 24 | 15.3% | -13.9% | ||
| Q2 24 | 14.3% | -16.8% | ||
| Q1 24 | 10.6% | -19.1% |
每股收益（稀释后）ALRMOFIX
| Q4 25 | $0.66 | $-0.05 | ||
| Q3 25 | $0.65 | $-0.57 | ||
| Q2 25 | $0.63 | $-0.36 | ||
| Q1 25 | $0.52 | $-1.35 | ||
| Q4 24 | $0.56 | $-0.76 | ||
| Q3 24 | $0.67 | $-0.71 | ||
| Q2 24 | $0.62 | $-0.88 | ||
| Q1 24 | $0.44 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $960.6M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $848.2M | $450.0M |
| 总资产 | $2.1B | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ALRMOFIX
| Q4 25 | $960.6M | $82.0M | ||
| Q3 25 | $1.1B | $62.9M | ||
| Q2 25 | $1.0B | $65.6M | ||
| Q1 25 | $1.2B | $58.0M | ||
| Q4 24 | $1.2B | $83.2M | ||
| Q3 24 | $1.2B | $30.1M | ||
| Q2 24 | $1.1B | $26.4M | ||
| Q1 24 | $747.9M | $27.0M |
总债务ALRMOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | — | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益ALRMOFIX
| Q4 25 | $848.2M | $450.0M | ||
| Q3 25 | $827.2M | $442.5M | ||
| Q2 25 | $797.3M | $458.3M | ||
| Q1 25 | $759.6M | $458.3M | ||
| Q4 24 | $726.5M | $503.1M | ||
| Q3 24 | $690.3M | $525.9M | ||
| Q2 24 | $645.5M | $546.0M | ||
| Q1 24 | $728.1M | $570.3M |
总资产ALRMOFIX
| Q4 25 | $2.1B | $850.6M | ||
| Q3 25 | $2.1B | $832.6M | ||
| Q2 25 | $2.1B | $837.2M | ||
| Q1 25 | $2.1B | $823.1M | ||
| Q4 24 | $2.0B | $893.3M | ||
| Q3 24 | $2.0B | $867.9M | ||
| Q2 24 | $1.9B | $882.0M | ||
| Q1 24 | $1.5B | $906.0M |
负债/权益比ALRMOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $35.9M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $35.1M | $16.8M |
| 自由现金流率自由现金流/营收 | 13.4% | 7.6% |
| 资本支出强度资本支出/营收 | 0.3% | 4.9% |
| 现金转化率经营现金流/净利润 | 1.04× | — |
| 过去12个月自由现金流最近4个季度 | $137.0M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流ALRMOFIX
| Q4 25 | $35.9M | $27.7M | ||
| Q3 25 | $70.6M | $12.4M | ||
| Q2 25 | $22.7M | $11.6M | ||
| Q1 25 | $24.1M | $-18.4M | ||
| Q4 24 | $56.3M | $23.7M | ||
| Q3 24 | $77.3M | $11.7M | ||
| Q2 24 | $23.0M | $9.0M | ||
| Q1 24 | $49.9M | $-18.6M |
自由现金流ALRMOFIX
| Q4 25 | $35.1M | $16.8M | ||
| Q3 25 | $65.9M | $2.5M | ||
| Q2 25 | $18.2M | $4.5M | ||
| Q1 25 | $17.9M | $-25.1M | ||
| Q4 24 | $54.0M | $15.2M | ||
| Q3 24 | $74.5M | $6.3M | ||
| Q2 24 | $21.0M | $-360.0K | ||
| Q1 24 | $46.8M | $-29.1M |
自由现金流率ALRMOFIX
| Q4 25 | 13.4% | 7.6% | ||
| Q3 25 | 25.7% | 1.2% | ||
| Q2 25 | 7.1% | 2.2% | ||
| Q1 25 | 7.5% | -13.0% | ||
| Q4 24 | 22.3% | 7.0% | ||
| Q3 24 | 31.0% | 3.2% | ||
| Q2 24 | 9.0% | -0.2% | ||
| Q1 24 | 21.0% | -15.4% |
资本支出强度ALRMOFIX
| Q4 25 | 0.3% | 4.9% | ||
| Q3 25 | 1.9% | 4.8% | ||
| Q2 25 | 1.8% | 3.5% | ||
| Q1 25 | 2.6% | 3.5% | ||
| Q4 24 | 0.9% | 4.0% | ||
| Q3 24 | 1.2% | 2.7% | ||
| Q2 24 | 0.9% | 4.7% | ||
| Q1 24 | 1.4% | 5.6% |
现金转化率ALRMOFIX
| Q4 25 | 1.04× | — | ||
| Q3 25 | 2.01× | — | ||
| Q2 25 | 0.66× | — | ||
| Q1 25 | 0.87× | — | ||
| Q4 24 | 1.87× | — | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 0.69× | — | ||
| Q1 24 | 2.11× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALRM
| License And Service | $180.2M | 69% |
| Hardwareand Other Revenue | $81.4M | 31% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
